Coronavirus disease 2019 and the placenta: A literature review

Samwel R Gesaka1, Moses M Obimbo2, Anthony Wanyoro3

  • 1Basic Clinical and Translational (BCT) Research Laboratory, University of Nairobi, Nairobi, Kenya.

Placenta
|July 25, 2022
PubMed

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can infect the placenta, affecting pregnancy. Viral entry mediators and pathogenesis mechanisms in placental tissues require further investigation.

Area of Science:

  • Obstetrics and Gynecology
  • Virology
  • Pathology

Background:

  • Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, impacts multiple organs.
  • Understanding SARS-CoV-2's role in placental pathology is crucial due to the virus's novelty.
  • Existing literature on placental SARS-CoV-2 infection requires synthesis.

Purpose of the Study:

  • To review and evaluate the existing literature on SARS-CoV-2 in the placenta.
  • To examine viral mediators, entry mechanisms, pathogenesis, detection, and pathology.
  • To identify knowledge gaps regarding placental SARS-CoV-2 infection.

Main Methods:

  • Systematic literature search yielding 96 eligible studies.
  • Analysis of studies reporting on SARS-CoV-2 mediators, receptors, and factors in placental tissues.
  • Review of methods for viral detection (in situ hybridization, PCR, etc.) and reported placental pathologies.

Main Results:

  • Canonical mediators (ACE2, TMPRSS2) and other factors (SCARFs) are expressed in placental cells, influencing viral permissiveness.
  • Viral RNA, proteins, and particles were detected primarily in syncytiotrophoblasts (STBs).
  • Observed placental pathologies included maternal-fetal vascular malperfusion and inflammatory responses.

Conclusions:

  • The placenta is predisposed to SARS-CoV-2 infection due to the expression of viral receptors and pathogenesis-related genes.
  • SARS-CoV-2 infection can occur across all pregnancy trimesters, potentially exacerbated by pre-existing placental conditions.
  • Further research is needed to fully elucidate the mechanisms of SARS-CoV-2 entry and pathogenesis in the placenta.

Related Concept Videos

Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.9K